Literature DB >> 22189699

Vaccination of neonates: problem and issues.

Douglas C Hodgins1, Patricia E Shewen.   

Abstract

Many serious infectious diseases occur early in life; efficacious vaccination of neonates has been a longstanding goal in both human and veterinary medicine. Efforts to immunize in the first weeks of life, in various species, have had limited success in general. This has been attributed to a combination of immaturity of the neonatal immune system and interference by maternal antibodies. Most studies of neonatal immune responsiveness have been carried out in neonatal mice, or by examination of cellular components of human umbilical cord blood. Both approaches have their limitations. The current review describes factors, including corticosteroids, complement proteins, cytokines, maternal lymphocytes and antibodies, which may influence immune responses of neonates, comparing data from studies of domestic animals and humans. Neonates are highly dependent on passive (maternal) antibodies for protection against a wide range of pathogens. These maternal antibodies have been noted to interfere with active immune responses to many, but not all, vaccines. Various theories have been proposed to explain this phenomenon, including epitope masking, clearance of immune complexes and FcγRII mediated regulation of B cells. Remarkably, many studies examining the effects of passive antibodies on immune responses of adults, have demonstrated immune enhancing effects. The evidence for enhancing and suppressive effects of passive antibodies on antigen uptake, processing and regulation of lymphocyte responses is reviewed. Since maternal antibodies (as present in neonates) differ in subisotypes and affinity from the passive antibodies often used in experimental systems, here is a need for better experimental models investigating the effects of bona fide maternal antibodies on immune responses of neonates (not adult surrogates). Vaccines can be optimized for use in neonates - by making better use of existing vaccine technologies and by harnessing the potential of recent immunological and technological advances.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189699     DOI: 10.1016/j.vaccine.2011.12.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

1.  Prenatal maternal anxiety predicts reduced adaptive immunity in infants.

Authors:  Thomas G O'Connor; Marcia A Winter; Julianne Hunn; Jennifer Carnahan; Eva K Pressman; Vivette Glover; Emma Robertson-Blackmore; Jan A Moynihan; F Eun-Hyung Lee; Mary T Caserta
Journal:  Brain Behav Immun       Date:  2013-02-21       Impact factor: 7.217

2.  Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.

Authors:  Fernando P Polack; Shari L Lydy; Sok-Hyong Lee; Paul A Rota; William J Bellini; Robert J Adams; Harriet L Robinson; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

3.  Exposure to infections and risk of leukemia in young children.

Authors:  Erin L Marcotte; Beate Ritz; Myles Cockburn; Fei Yu; Julia E Heck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-03       Impact factor: 4.254

4.  Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Authors:  Elinor Willis; Norbert Pardi; Kaela Parkhouse; Barbara L Mui; Ying K Tam; Drew Weissman; Scott E Hensley
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

Review 5.  The potential of the microbiota to influence vaccine responses.

Authors:  David J Lynn; Bali Pulendran
Journal:  J Leukoc Biol       Date:  2017-12-28       Impact factor: 4.962

6.  α-Galactosylceramide stimulates splenic lymphocyte proliferation in vitro and increases antibody production in vivo in late neonatal-age mice.

Authors:  Q Chen; A C Ross
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

Review 7.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

8.  The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.

Authors:  Anne E Mayer; John B Johnson; Griffith D Parks
Journal:  Virology       Date:  2014-05-29       Impact factor: 3.616

9.  Impaired Development and Expansion of Germinal Center Follicular Th Cells in Simian Immunodeficiency Virus-Infected Neonatal Macaques.

Authors:  Huanbin Xu; Widade Ziani; Jiasheng Shao; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Marion S Ratterree; Ronald S Veazey; Xiaolei Wang
Journal:  J Immunol       Date:  2018-08-13       Impact factor: 5.422

Review 10.  Immunological assessment of influenza vaccines and immune correlates of protection.

Authors:  Adrian Reber; Jacqueline Katz
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.